Leap Therapeutics Inc.

LPTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.77

-$0.02 (-3.10%)

At close: Apr 01, 2026, 09:30 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.15%

(1Y)

Key Statistics

Market Data

Market Cap $31.86M

1D Range

0.74 0.80

52W Range

0.22 3.58

Valuation (TTM)

PE 1.22

PB 0.23

EV/EBITDA -1.37

Valuation (NTM)

Forward PE 2.65

Forward PEG -0.00

Price Target $5.50

Cash Flow

FCF Yield -200.4%

SBC Adj. FCF Yield -219.4%

SBC Impact -9.5%

Margins

Gross Margin -9631.6%

Operating Margin -8504.8%

FCF Margin -30551.2%

Growth (CAGR)

Revenue 3Y | 5Y -60.7% | -51.4%

Dil EPS 3Y | 5Y 133.7% | 55.5%

FCF 3Y | 5Y -11.9% | -10.3%

Returns

ROA 25.8%

ROE 23.8%

ROIC -12.6%

Financial Health

Net Cash

$7.59M

Current Ratio 79.19

Interest Coverage 8,887.50

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.